ALL MARKETS
FTSE 100
FTSE 250
AIM MARKET


GlaxoSmithKline PLC.
275 announcements.
Time Ticker Company Announcement
15:51 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
16:22 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
16:36 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
17:35 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
17:19 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
09:53 GSK GlaxoSmithKline PLC
Total Voting Rights
13:34 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
17:32 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
12:07 GSK GlaxoSmithKline PLC
Second Price Monitoring Extn
12:02 GSK GlaxoSmithKline PLC
Price Monitoring Extension
08:00 GSK GlaxoSmithKline PLC
GSK divests two travel vaccines to Bavarian Nordic
17:00 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
17:00 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
17:00 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
17:00 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
17:34 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
16:10 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
16:18 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
13:09 GSK GlaxoSmithKline PLC
Total Voting Rights
07:00 GSK GlaxoSmithKline PLC
PRIMA shows Zejula improves PFS in ovarian cancer
07:00 GSK GlaxoSmithKline PLC
Data show anti-tumour activity with ICOS agonist
17:46 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
16:30 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
17:37 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
12:36 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
09:33 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
11:29 GSK GlaxoSmithKline PLC
Total Voting Rights
07:00 GSK GlaxoSmithKline PLC
GSK - positive results from pivotal DREAMM-2 study
07:00 GSK GlaxoSmithKline PLC
ViiV results positive for every 2 month injection
08:00 GSK GlaxoSmithKline PLC
GSK submits regulatory file in Japan: Daprodustat
15:45 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
15:30 GSK GlaxoSmithKline PLC
EU approval for Nucala self-administration
14:10 GSK GlaxoSmithKline PLC
Total Voting Rights
07:00 GSK GlaxoSmithKline PLC
GSK completes transaction with Pfizer for New JV
15:35 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
07:00 GSK GlaxoSmithKline PLC
ViiV submits cabotegravir to EMA for HIV injection
16:01 GSK GlaxoSmithKline PLC
ViiV 2DR TANGO switch study positive at 48 weeks
16:00 GSK GlaxoSmithKline PLC
ViiV GEMINI studies show high efficacy at 96 weeks
12:07 GSK GlaxoSmithKline PLC
Second Price Monitoring Extn
12:02 GSK GlaxoSmithKline PLC
Price Monitoring Extension
12:00 GSK GlaxoSmithKline PLC
2nd Quarter Results
10:00 GSK GlaxoSmithKline PLC
Non-Executive Chairman
17:00 GSK GlaxoSmithKline PLC
ViiV presents 96-week data from phase III study
11:42 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
07:00 GSK GlaxoSmithKline PLC
positive results in Phase 3 PRIMA study of ZEJULA
16:35 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
15:55 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
15:48 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
07:00 GSK GlaxoSmithKline PLC
ViiV switch study shows 2DR as effective as 3DR
09:00 GSK GlaxoSmithKline PLC
ViiV receives Dovato EU Marketing Authorisation
12:08 GSK GlaxoSmithKline PLC
Total Voting Rights
17:10 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
07:00 GSK GlaxoSmithKline PLC
FDA approval for Nucala self-administration
08:00 GSK GlaxoSmithKline PLC
CHMP positive on GSK's Nucala self-administration
14:31 GSK GlaxoSmithKline PLC
Total Voting Rights
10:54 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
13:44 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
17:44 GSK GlaxoSmithKline PLC
Block listing Interim Review
16:19 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
17:07 GSK GlaxoSmithKline PLC
Trelegy Ellipta asthma study met primary endpoint
15:11 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
14:32 GSK GlaxoSmithKline PLC
Total Voting Rights
12:00 GSK GlaxoSmithKline PLC
1st Quarter Results
12:00 GSK GlaxoSmithKline PLC
ViiV submits NDA for HIV monthly 2 drug injectable
17:36 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
17:35 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
17:23 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
17:14 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
14:45 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
16:33 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
07:00 GSK GlaxoSmithKline PLC
FDA approves ViiV's two-drug HIV regimen, Dovato
13:00 GSK GlaxoSmithKline PLC
Publication of AGM and GM Shareholder Documents
16:15 GSK GlaxoSmithKline PLC
GSK reporting changes - product sales and IFRS 16
17:02 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
17:45 GSK GlaxoSmithKline PLC
Data from GARNET study evaluating dostarlimab
07:00 GSK GlaxoSmithKline PLC
GSK Annual Report 2018 on Form 20-F
15:19 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
13:00 GSK GlaxoSmithKline PLC
Annual Financial Report
18:24 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
07:00 GSK GlaxoSmithKline PLC
ViiV positive ph3 data for long acting injectable
10:10 GSK GlaxoSmithKline PLC
Total Voting Rights
17:30 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
11:21 GSK GlaxoSmithKline PLC
GSK response to SFO Statement
16:37 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
16:15 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
14:44 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
14:26 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
13:53 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding Replacement
13:41 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
17:13 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
16:14 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
17:39 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
10:33 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
14:05 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
14:03 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
12:42 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
12:40 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
12:38 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
12:02 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
12:01 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
12:16 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
12:17 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
12:20 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
12:01 GSK GlaxoSmithKline PLC
Final Results
11:58 GSK GlaxoSmithKline PLC
GSK and Merck announce global alliance for M7824
15:45 GSK GlaxoSmithKline PLC
Total Voting Rights
13:10 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
13:56 GSK GlaxoSmithKline PLC
GSK completes acquisition of TESARO
07:00 GSK GlaxoSmithKline PLC
GSK Chairman succession process
17:15 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
16:09 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
15:01 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
14:59 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
14:56 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
14:47 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
12:00 GSK GlaxoSmithKline PLC
GlaxoSmithKline Extends Tender Offer for TESARO
16:32 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
16:25 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
13:45 GSK GlaxoSmithKline PLC
Total Voting Rights
17:15 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
07:00 GSK GlaxoSmithKline PLC
GSK and Pfizer create new Consumer Healthcare JV
13:20 GSK GlaxoSmithKline PLC
GSK Commences Tender Offer for TESARO Inc.
16:35 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
10:07 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
14:00 GSK GlaxoSmithKline PLC
Total Voting Rights
12:02 GSK GlaxoSmithKline PLC
GSK reaches agreement to acquire TESARO
08:35 GSK GlaxoSmithKline PLC
GSK to divest Horlicks to Unilever
16:40 GSK GlaxoSmithKline PLC
Second Price Monitoring Extn
16:35 GSK GlaxoSmithKline PLC
Price Monitoring Extension
15:40 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
11:45 GSK GlaxoSmithKline PLC
GSK - Update on Review of Horlicks
15:25 GSK GlaxoSmithKline PLC
Block listing Interim Review
13:02 GSK GlaxoSmithKline PLC
GSK publishes 2019 Dividend Dates
14:45 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
09:00 GSK GlaxoSmithKline PLC
Blocklisting Application
12:43 GSK GlaxoSmithKline PLC
Director Declaration
16:15 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
13:40 GSK GlaxoSmithKline PLC
Total Voting Rights
14:15 GSK GlaxoSmithKline PLC
ViiV positive phIII results with fostemsavir
12:07 GSK GlaxoSmithKline PLC
Second Price Monitoring Extn
12:02 GSK GlaxoSmithKline PLC
Price Monitoring Extension
12:00 GSK GlaxoSmithKline PLC
3rd Quarter Results
14:30 GSK GlaxoSmithKline PLC
ViiV: positive data for long-acting injectable
10:00 GSK GlaxoSmithKline PLC
ViiV - three-year data for long-acting injectable
16:00 GSK GlaxoSmithKline PLC
ViiV submits HIV 2DR regulatory application to FDA
09:34 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
17:56 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
17:50 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
11:30 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
16:53 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
09:30 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
09:30 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
15:30 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
13:58 GSK GlaxoSmithKline PLC
Total Voting Rights
16:35 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
12:30 GSK GlaxoSmithKline PLC
CHMP recommends expansion of Trelegy COPD label
09:00 GSK GlaxoSmithKline PLC
ViiV submits HIV 2DR regulatory application to EMA
17:43 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
08:00 GSK GlaxoSmithKline PLC
New analysis on efficacy of anti-IL5 biologics SEA
07:00 GSK GlaxoSmithKline PLC
GSK receives CRL from FDA for mepolizumab in COPD
14:24 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
14:18 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
17:00 GSK GlaxoSmithKline PLC
Total Voting Rights
17:12 GSK GlaxoSmithKline PLC
GSK publishes Q4 2018 Dividend Dates
08:12 GSK GlaxoSmithKline PLC
EU approve Nucala in severe asthma in children
10:16 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
07:00 GSK GlaxoSmithKline PLC
Positive headline results for ViiV HC ATLAS study
15:00 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
12:35 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
07:00 GSK GlaxoSmithKline PLC
Iain Mackay appointed GSK Chief Financial Officer
11:04 GSK GlaxoSmithKline PLC
Total Voting Rights
17:03 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
16:37 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
16:30 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
14:47 GSK GlaxoSmithKline PLC
CHMP recommend Nucala for severe asthma children
07:00 GSK GlaxoSmithKline PLC
GSK reports on FDA Ad Com on mepolizumab for COPD
16:15 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
11:00 GSK GlaxoSmithKline PLC
2nd Quarter Results
11:00 GSK GlaxoSmithKline PLC
GSK and 23andMe Agreement
09:01 GSK GlaxoSmithKline PLC
ViiV announces Juluca 100 week data at AIDS 2018
09:00 GSK GlaxoSmithKline PLC
ViiV shows positive phIII data on two-drug combo
16:45 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
17:46 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
16:54 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
16:49 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
14:51 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
11:11 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
16:16 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
16:16 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
14:42 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
14:30 GSK GlaxoSmithKline PLC
Total Voting Rights
07:00 GSK GlaxoSmithKline PLC
Positive headline results for ViiV GEMINI studies
17:15 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
14:00 GSK GlaxoSmithKline PLC
GSK announces changes to Corporate Executive Team
13:00 GSK GlaxoSmithKline PLC
GSK completes Consumer Healthcare buyout
09:42 GSK GlaxoSmithKline PLC
Total Voting Rights
07:00 GSK GlaxoSmithKline PLC
GSK Once-daily single inhaler triple therapy COPD
11:02 GSK GlaxoSmithKline PLC
ViiV granted EU marketing authorisation for Juluca
14:00 GSK GlaxoSmithKline PLC
Director Shareholding
13:54 GSK GlaxoSmithKline PLC
Total Voting Rights
15:33 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
09:04 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
09:18 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
17:59 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
17:54 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
17:34 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
17:48 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
17:19 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
17:17 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
15:22 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
09:00 GSK GlaxoSmithKline PLC
GSK's Relvar Ellipta - positive CHMP opinion
12:30 GSK GlaxoSmithKline PLC
GSK's Shingrix - positive CHMP opinion in Europe
11:52 GSK GlaxoSmithKline PLC
Total Voting Rights
13:19 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
12:01 GSK GlaxoSmithKline PLC
Final Results
09:04 GSK GlaxoSmithKline PLC
GSK's Bexsero FDA Breakthrough Therapy Designation
07:00 GSK GlaxoSmithKline PLC
ViiV files patent infringement litigation
09:31 GSK GlaxoSmithKline PLC
ViiV Healthcare launches new two-drug HIV study
12:47 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
14:43 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
16:44 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
09:00 GSK GlaxoSmithKline PLC
GSK submits landmark IMPACT data - Trelegy Ellipta
17:53 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
18:09 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
17:57 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
11:20 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
17:25 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
17:29 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
18:12 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
13:16 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
13:17 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
13:15 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
16:54 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
11:16 GSK GlaxoSmithKline PLC
Total Voting Rights
13:11 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
14:47 GSK GlaxoSmithKline PLC
Nucala OSMO study presented at AAAAI-WAO congress
12:04 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
17:01 GSK GlaxoSmithKline PLC
ViiV Healthcare announces new dolutegravir data
08:00 GSK GlaxoSmithKline PLC
GSK announces labelling update to Relvar Ellipta
16:30 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
14:10 GSK GlaxoSmithKline PLC
Annual Financial Report
07:00 GSK GlaxoSmithKline PLC
GSK 2017 Form 20-F
07:44 GSK GlaxoSmithKline PLC
Update regarding Pfizer Inc. Consumer Healthcare
11:21 GSK GlaxoSmithKline PLC
ViiV - CHMP positive opinion for Juluca in Europe
07:00 GSK GlaxoSmithKline PLC
Shingrix approved in Europe and Japan
07:00 GSK GlaxoSmithKline PLC
GSK agrees to acquire CH business from Novartis
13:00 GSK GlaxoSmithKline PLC
Notice of AGM
16:14 GSK GlaxoSmithKline PLC
Total Voting Rights
15:04 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
15:44 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
11:32 GSK GlaxoSmithKline PLC
Notice of GM
15:50 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
13:20 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
13:30 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
13:36 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
13:24 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
13:47 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
10:34 GSK GlaxoSmithKline PLC
Landmark IMPACT study to be published in NEJM
07:00 GSK GlaxoSmithKline PLC
IMPACT study shows benefits of Trelegy Ellipta
15:15 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
15:15 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
17:41 GSK GlaxoSmithKline PLC
Trelegy Ellipta expanded US COPD indication
12:07 GSK GlaxoSmithKline PLC
Second Price Monitoring Extn
12:00 GSK GlaxoSmithKline PLC
1st Quarter Results
12:02 GSK GlaxoSmithKline PLC
Price Monitoring Extension
15:30 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
12:43 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
14:45 GSK GlaxoSmithKline PLC
Total Voting Rights
18:31 GSK GlaxoSmithKline PLC
Result of General Meeting
18:29 GSK GlaxoSmithKline PLC
Result of AGM
17:05 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding - replacement
12:00 GSK GlaxoSmithKline PLC
Directorate Change
17:20 GSK GlaxoSmithKline PLC
Block listing Interim Review
15:17 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding
13:39 GSK GlaxoSmithKline PLC
Director/PDMR Shareholding